Skip to content
All news
Earnings

WW International Reaffirms 2026 Outlook After Q1 Results

WW International (WeightWatchers) reported Q1 2026 results with continued pressure on legacy behavioral subscriptions, partially offset by growth in clinical weight management and higher-value services. The company reaffirmed its 2026 financial outlook.

May 9, 2026
2 min read
Source: MarketBeat
Share:

WW International (NASDAQ:WW), the operator of WeightWatchers, reported first-quarter 2026 results that reflected continued pressure in its legacy behavioral subscription business, offset in part by growth in its clinical weight-management offering and higher-value services. The company reaffirmed its 2026 financial outlook.

Key Financial Results

MetricQ1 2026YoY Change
RevenueNot disclosed-
Net IncomeNot disclosed-
EPSNot disclosed-

Note: Specific revenue or profit figures were not provided in the initial report. The table will be updated when data becomes available.

Highlights from the Statement

  • Continued pressure on behavioral subscription business due to competition and changing consumer preferences.
  • Growth in clinical weight management segment, including prescription-based offerings.
  • Increased demand for higher-value services, contributing to margin improvement.

Future Guidance

WW International reaffirmed its full-year 2026 financial outlook, though no specific revenue or profit ranges were disclosed.

Stock Impact

The stock (NASDAQ:WW) showed no significant movement following the announcement, as investors await further details on segment performance.

What This Means for Investors

The results indicate that WW International is in a transition phase, shifting from traditional behavioral subscriptions to clinical and prescription-based services. This shift could drive long-term growth but carries execution and competitive risks. Investors should monitor revenue and profit trends in coming quarters to assess the strategy's success.

Frequently Asked Questions

The company reported continued pressure on behavioral subscriptions, with growth in clinical offerings. Specific revenue or profit figures were not disclosed.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.